Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs  by Widjaja, Linda et al.
6) 137–145
www.elsevier.com/locate/yviroVirology 350 (200Molecular changes associated with adaptation of human influenza A
virus in embryonated chicken eggs
Linda Widjaja a,b, Natalia Ilyushina a, Robert G. Webster a,c, Richard J. Webby a,⁎
a Division of Virology, Department of Infectious Diseases, Mail Stop 330, St. Jude ChildrenT s Research Hospital, 332 N. Lauderdale St., Memphis, TN 38105, USA
b Integrated Program in Biomedical Sciences, The University of Tennessee Health Science Center, Memphis, TN 38163, USA
c Department of Pathology, The University of Tennessee Health Science Center, Memphis, TN 38163, USA
Received 2 December 2005; returned to author for revision 4 January 2006; accepted 13 February 2006
Available online 20 March 2006Abstract
Failure to isolate A/Fujian/411/2002 (H3N2) in embryonated chicken eggs resulted in its absence from the 2003/2004 vaccine. We analyzed
the adaptation of this virus in eggs during serial passages in the amniotic then allantoic cavities. Amniotic passage allowed the virus to grow in the
allantoic cavity. During adaptation, 6 amino acid substitutions occurred: 4 in HA (G186V, S219F, V226I, V309I) and 2 in NA (E119Q, Q136K).
These substitutions allowed binding to SAα2,3Gal- and SAα2,6Gal-containing receptors, conferred SAα2,3Gal specificity, and preserved
antigenicity. Two HA substitutions (G186V, V226I) were sufficient to improve growth. Changing 2 NA residues (E119Q, Q136K) did not
improve growth, and adaptation did not result in the HA changes H183L, D188Y, and V226A found by others. These findings suggest that viral
adaptation in eggs involves multiple strategies. Vaccine manufacture will benefit from increased understanding of adaptation and strategies to
improve human influenza A virus replication in eggs.
© 2006 Elsevier Inc. All rights reserved.Keywords: Influenza A virus; Embryonated chicken eggs; Adaptation; Reverse geneticsIntroduction
The principal means of protection against influenza is
vaccination (Centers for Disease Control and Prevention, 2005).
Vaccines approved for use in the U.S. (inactivated or live
attenuated vaccine) must contain components from an H1N1, an
H3N2, and a B virus (i.e., the vaccine is trivalent). The H1N1
and H3N2 components are reassortant viruses having replica-
tive genes from a master donor strain and the genes encoding
the surface proteins, hemagglutinin (HA) and neuraminidase
(NA), from circulating virus. The manufacture of trivalent
vaccine relies upon large-scale cultivation of the 3 vaccine
components in the allantoic cavity of chickens' eggs, and
because of antigenic drift, the composition of the vaccine has to
be reformulated annually (Gerdil, 2003). The World Health
Organization (WHO) predicted that, in the 2003/2004 influenza
season, the virus A/Fujian/411/2002 (H3N2) (Fujian) would be⁎ Corresponding author. Fax: +1 901 523 2622.
E-mail address: richard.webby@stjude.org (R.J. Webby).
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doi:10.1016/j.virol.2006.02.020the predominant strain. However, numerous attempts to grow
this virus in the egg allantoic cavity in time for its inclusion in
vaccine were unsuccessful. Thus, the only virus available was
that isolated in non-validated MDCK cells. Virus isolated in this
way cannot be used in vaccine manufacture. Consequently, the
H3N2 component of the vaccine remained unchanged. Fujian
did indeed predominate in the 2003/2004 season, and the
mismatch between the circulating and vaccine strains resulted in
an increase in influenza incidents, especially in children
(Centers for Disease Control and Prevention, 2004).
The method of isolating influenza virus in embryonated
chickens' eggs was devised in the 1930s by Frank Macfarlane
Burnet, who reported that influenza virus can be adapted for
better growth by subjecting it to serial passages in the allantoic
cavity (Burnet and Bull, 1943). Human influenza A virus was
later shown to be able to replicate unrestrictedly within the
amnion and to replicate more efficiently in the allantoic cavity
after initial amniotic passages (Robertson et al., 1993). The
amniotic and allantoic compartments of embryonated chick-
ens' eggs possess receptors with different characteristics. A
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(Gal) by an α2,3 or an α2,6 linkage. Amniotic cells possess both
types of receptors (SAα2,3Gal and SAα2,6Gal), whereas
allantoic cells possess only the SAα2,3Gal receptor (Ito et al.,
1997). Influenza viruses bind to and recognize SAs in specific
linkages, and the receptor-binding preferences of influenza
viruses are specific to the animal species from which the virus
was isolated. Human influenza A viruses, for example, pre-
ferentially bind to receptors in which 5-N-acetylneuraminic acid
(Neu5Ac) is α2,6 linked to galactose (i.e., Neu5Acα2,6Gal
receptors; Rogers and Paulson, 1983). Growth of virus in eggs
can change the virus's receptor-binding specificity through
alteration around the HA's receptor-binding sites (Azzi et al.,
1993; Katz et al., 1987; Rocha et al., 1993; Rogers et al., 1983;
Williams and Robertson, 1993; Robertson et al., 1987). Human
influenza A viruses remain specific for SAα2,6Gal receptors
when grown for up to 2 passages in the amniotic cavity, but after
further allantoic passages, they acquire SAα2,3Gal specificity
(Gambaryan et al., 1999; Ito et al., 1997). However, the under-
lying mechanism of this adaptation remains unknown.
The use of embryonated chickens' eggs remains, until an
alternative substrate is approved, the most economical and
practical way to cultivate influenza viruses for vaccine
production. Therefore, understanding the molecular basis for
adaptation of the virus in eggs is crucial. The first objective
of the present study was to identify which amino acids are
altered during the adaptation of Fujian in eggs. Our next
objective was to address the following key questions. First,
what is the importance of these amino acids? A recent study
using Fujian on an A/Ann Arbor/6/66 (H2N2) backbone (the
master strain used to create live attenuated vaccine) indicated
that amino acid changes that influence the activities of HA
and NA can improve the virus's ability to replicate in the
allantoic cavity (Lu et al., 2005). Second, if a balance
between HA and NA activities is crucial for efficient
replication of influenza A virus (Lu et al., 2005; Wagner et
al., 2002), does this balance also play a role in the egg growth
of Fujian on a different backbone? Third, because adaptation
in eggs is associated with alteration of receptor-binding
properties (Gambaryan et al., 1999), does Fujian undergo
changes in receptor specificity during adaptation? Finally,
because the preservation of antigenicity is important in
vaccine manufacture, we examined the relation between the
amino acids we observed to be involved in the adaptation
process and viral antigenicity.
Results
Amino acid substitutions observed during the adaptation of
Fujian in embryonated chicken eggs
To identify the amino acid residues involved in adaptation in
eggs, we examined the virus at each step of the adaptation
process (Fig. 1). We detected virus by using the hemaggluti-
nation assay. Each passage began with inoculation of 3 groups
of 5 eggs: 1 group via the amniotic cavity (AM), 1 via the
allantoic cavity (AL), and 1 via both routes (AM/AL).First, we inoculated the eggs with Fujian that had been
propagated in Madin–Darby canine kidney (MDCK) cells.
After 48 h, we detected virus only in the amniotic fluid of 1 of
the 5 eggs of the AM/AL group (Fig. 1, “Inoculum route and
virus growth”). This virus had 2 altered amino acids: V309I in
HA and Q136K in NA (Fig. 1, bottom 2 panels). We then
injected this virus into a second set of 15 eggs. After this second
passage, we harvested virus from the amniotic fluid of 2 eggs of
the AM/AL group. This virus had the same 2 amino acid
changes as the previous one and no additional changes. We
continued to perform serial passages in a similar fashion (using
the virus isolated after the previous passage to inoculate the next
set of eggs) for a total of 6 passages, fully sequencing the
progeny virus at each step. Replication of the virus improved
after each passage, with virus being detectable in increasing
numbers of inoculated eggs. After the fourth passage, we began
to detect virus in the allantoic cavity, and from here on, we
injected virus only into the allantoic cavity. After 2 additional
passages, we detected virus in all inoculated eggs. These viruses
had 4 amino acid changes in HA (G186V, S219F, V226I, and
V309I), but only 1 change in NA (Q136K). A second change in
NA (E119Q) was observed after passage 3, but reverted after
passage 5. We observed no amino acid changes in proteins other
than HA and NA.
This experiment showed that initial growth of the virus in the
amniotic cavity increases the virus's replication efficiency in the
allantoic cavity, as has been shown previously (Robertson et al.,
1993). Three passages in the amniotic cavity were needed to
achieve replication in the allantoic cavity. However, further
passages in the allantoic cavity were necessary for full
adaptation in the allantoic cavity. Our sequence data indicate
that replication in the allantoic cavity may require 1 amino acid
change in NA (E119Q) but that additional changes around the
globular head region of HA are necessary to establish a full
adaptation in the allantoic cavity. Finally, we identified 6 amino
acid changes (4 in HA and 2 in NA) that appear to be implicated
in the adaptation of Fujian in embryonated chickens' eggs.
The importance of the amino acid residues observed in egg
adaptation
To confirm that these amino acid changes improve the
replication of Fujian in the allantoic cavity, we used reverse
genetics to generate viruses with wild-type or adapted Fujian
HA, NA, or both on a backbone of A/Puerto Rico/8/34 (H1N1)
(PR8, the master strain used to generate inactivated vaccine).
All viruses generated replicated in MDCK cells, but only that
bearing the HA and NA of the adapted Fujian grew to a high
titer in the allantoic cavity (Table 1).
To determine which of the Fujian's surface proteins is
responsible for its inability to grow in eggs, we generated
PR8-based viruses bearing the Fujian HA or NA. That
carrying the wild-type HA replicated poorly in the allantoic
cavity (Table 1, virus 1c), whereas that carrying wild-type NA
replicated well (virus 1d). This result suggests that the
responsibility for Fujian's inability to grow in eggs lies with
the HA.
Fig. 1. Passage history and sequence changes required for replication of Fujian in embryonated chicken eggs. The row labeled “Inoculum route and virus growth”
indicates the egg compartment (amniotic or allantoic fluid) from which the virus was isolated and, in parentheses, the numbers of positive eggs per group (5 eggs each)
inoculated by the route indicated (AM/AL, both amniotic and allantoic; AM, amniotic; AL, allantoic). The bold and underline routes indicate the pooled source of
inoculum for the subsequent passage, for example, in passages 2 and 3, the inoculum was derived from amniotic fluid. The next row (“inoculum titer”) indicates the
hemagglutination titer of the virus inoculated into eggs in the subsequent passage. At each passage level, each positive single egg harvest is sequenced, but pooled
harvest is used as inoculum for subsequent passage. The amino acid sequence changes observed after each passage are shown on the structures of the trimeric HA
molecule (only 1 monomer is shown) and the NA molecule.
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or NA (or both) containing 1 or more of the substitutions found
in the adapted virus. Viruses bearing wild-type HA and NAwith
1 substitution (E119Q or Q136K) replicated at low titer (Table
1, viruses 2e and 2f, respectively), as did those bearing wild-
type NA and HA with 1 change (G186V, S219F, V226I, or
V309I; viruses 2a–2d). Viruses with these singly substituted
HAs and NAwith the substitution Q136K also replicated poorly
(data not shown and Table 1, virus 5a).
Interestingly, virus with the HA substitutions G186V and
V226I and wild-type NA replicated well in the allantoic cavity
(Table 1, virus 3b); the titer of the same virus with the additional
NA substitution Q136K was slightly lower (data not shown).
The other 2 combinations of HA substitutions (G186V and
S219F or S219F and V226I) with wild-type NA or Q136K-
substituted NA conferred poor replicative ability (Table 1,
viruses 3a and 3c, respectively; and data not shown).
Virus with 3 changes in the HA (G186V, S219F, and V226I)
and wild-type NA replicated well in the allantoic cavity (Table
1, virus 4a), as did the same virus with the NA substitution
Q136K (data not shown). In contrast, viruses with the other 3HA substitutions (either G186V, S219F, and V309I or S219F,
V226I, and V309I) and wild-type NA (Table 1, viruses 4b and
4c, respectively) replicated to a much lower titer.
We also generated PR8-based viruses bearing Fujian HA or
NA (or both) with the amino acid substitutions we observed at
each passage during adaptation in eggs (Table 1, groups 1 and 5).
Virus corresponding to that resulting from the first 2 passages
(HA, V309I; NA, Q136K) grew at a low titer in the allantoic
cavity (Table 1, virus 5a). Virus corresponding to those resulting
from the third and fourth passages (HA, V309I; NA, E119Q and
Q136K) also grew at a low titer (Table 1, virus 5b). However,
viruses with V309I in the HA and a single mutation in the NA
(E119Q or Q136K) replicated to a slightly lower titer than did
those with both mutations in the NA (Table 1, viruses 5c and 5a,
respectively). Virus corresponding to those obtained at passages
5 and 6 (HA with G186V, S219F, V226I, and V309I; NA with
Q136K; Table 1, virus 1b) replicated to a titer similar to that of
the same virus with wild-type Fujian NA (Table 1, virus 5d).
These results indicate that the most important factor in the
inability of Fujian to grow in eggs is the HA. Most important in
adaptation in the allantoic cavity were the HAmutations G186V
Table 1
Characteristics of viruses generated by using reverse genetics
Virus with 6 genes of PR8 Virus titer
HA NA Hemagglutination titer in a MDCK plaque assay in








(avg mm ± SD) e
wt G186V S219F V226I V309I wt E119Q Q136K
1a f + + 0 256 3.1 ± 0.1 2.5 ± 0.4
1b + + + + + 2048 1024 8.0 ± 0.2 <0.5
1c + + 0 256 1.8 ± 0.3 2.0 ± 0.4
1d + + 2048 1024 7.9 ± 0.1 2.5 ± 0.4
2a g + + 0 512 3.9 ± 0.4 2.5 ± 0.3
2b + + 0 256 2.7 ± 0.5 2.5 ± 0.5
2c + + 0 1024 3.8 ± 0.3 2.5 ± 0.6
2d + + 0 256 1.8 ± 0.2 1.1 ± 0.1
2e + + 0 128 1.7 ± 0.1 1.0 ± 0.2
2f + + 0 128 1.7 ± 0.2 0.5 ± 0.1
3a h + + + 0 256 1.7 ± 0.2 2.5 ± 0.4
3b + + + 512 512 7.3 ± 0.2 2.5 ± 0.2
3c + + + 0 128 1.5 ± 0.1 2.5 ± 0.3
3d + + + 0 256 1.8 ± 0.2 <0.5
4a i + + + + 512 1024 7.9 ± 0.5 2.5 ± 0.1
4b + + + + 4 j 128 2.4 ± 0.1 2.0 ± 0.3
4c + + + + 2 j 128 2.0 ± 0.1 1.5 ± 0.4
5a k + + 0 128 1.7 ± 0.2 1.0 ± 0.3
5b + + + 2 j 128 2.5 ± 0.3 0.5 ± 0.1
5c + + 0 256 2.0 ± 0.3 0.5 ± 0.1
5d + + + + + 512 1024 8.1 ± 0.2 2.5 ± 0.4
a Average from 2 independent experiments.
b Average HA titer obtained by using 0.5% CRBCs.
c Average HA titer obtained by using 0.5% TRBCs.
d Virus titers are expressed as the average (avg) log PFU/ml ± standard deviation (SD) obtained from 2 independent experiments.
e Plaque sizes are expressed as the average (avg) of 10 plaques in millimeters (mm) ± SD.
f Group 1 viruses have HA and/or NA of adapted virus, wild-type (wt) Fujian virus, or PR8.
g Group 2 viruses have single substitutions in HA or NA and wild-type (wt) Fujian virus NA or HA.
h Group 3 viruses have double substitutions in HA or NA and wild-type (wt) Fujian virus NA or HA.
i Group 4 viruses have triple substitutions in HA and wild-type (wt) Fujian virus NA.
j Average from 3 independent experiments.














Affinity of the viruses for sialyl substrates
Virus a Kdiss ± SD
b
Fetuin p6′SL p3′SL
wt 4.55 ± 0.80 >100 >100
G186V 6.24 ± 0.77 3.29 ± 0.75 0.23 ± 0.05
V226I 5.13 ± 0.72 1.74 ± 0.69 0.17 ± 0.04
S219F 7.66 ± 0.53 >100 0.22 ± 0.12
V309I 5.50 ± 0.90 >100 >100
G186V, V226I 7.72 ± 0.99 5.79 ± 0.89 0.51 ± 0.15
G186V, V226I, V309I 4.80 ± 0.53 7.29 ± 0.57 0.39 ± 0.123
a Viruses were generated with HA of wild-type (wt) Fujian virus or with the
indicated substitution(s) and wild-type Fujian virus NA on a PR8 background.
b Mean from 4 independent experiments. The higher the value, the lower the
affinity.
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first step of adaptation.
Relation between NA activity and virus replication in eggs
A balance between HA and NA activities is crucial for the
efficient replication of influenza A virus (Wagner et al., 2002):
altered activity of either protein will affect viral replication. We
have shown (above) that changes in HA result in better
replication in eggs. Next, we examined the effects of the
observed changes in the Fujian's NA on NA activity and the
ability of the virus to replicate in eggs. NA activities in the 3
mutant viruses (NAwith E119Q, Q136K, or both substitutions)
were similar and lower than that of virus with wild-type Fujian
NA on a PR8 backbone (Fig. 2). In addition, plaque assay
(Table 1 and data not shown) showed that most of the PR8-
based viruses with the NA mutation(s) E119Q, Q136K, or both
produced smaller plaques (<1.5 mm) than did those with wild-
type Fujian NA (>1.5 mm), with the exception of 1 PR8-based
virus with V309I in HA and wild-type Fujian NA, which
produced small plaques (<1.5 mm; Table 1, virus 2d). These
results show that NA activity is reduced during adaptation in
eggs.
Receptor specificity changes accompanying egg adaptation
Adaptation in eggs is associated with alteration of receptor-
binding properties (Gambaryan et al., 1999). We performed a
rigorous chemical assay to determine the receptor-binding
specificities of mutant viruses, i.e., which type of receptor (α2,3
or α2,6) is being bound by these viruses. We took our panel of
viruses and measured their affinities to high molecular weight
SA substrates, both natural (fetuin) and synthetic (3′- and 6′-
sialyllactose attached to a polyacrylic carrier: p3′SL represent-
ing the α2,3 linkage, and p6SL representing the α2,6 linkage)
(Table 2). These sialyl molecules contain carbohydrate chains ofFig. 2. NA activities of wild-type Fujian (filled squares) and viruses with the NA
substitutions E119Q (filled circles), Q136K (filled triangles), or E119Q and
Q136K (open diamonds). Note that the NA activities of viruses with either
substitution (E119Q, filled circles; or Q136K, filled triangles) had overlapping
values.natural glycoproteins and glycolipids, which are potential
receptors for influenza A viruses. In this assay, the lower the
dissociation constant (Kdiss), the stronger the bond between
virus and receptor. Fetuin contains both α2,3 and α2,6 linked
sialic acids of complex compositions and is used as a positive
binding control.
We found that the wild-type virus and virus carrying HA
with the single substitution V309I have negligible affinity to
the p3′SL and p6SL substrates (Table 2). Viruses bearing HA
with the single mutation G186V or V226I exhibited affinity to
both synthetic substrates, but their affinity to p3′SL was
approximately 10 times as high as that to p6SL. Similarly,
viruses with double or triple amino acid substitutions in the
HA (G186V and V226I or G186V, V226I, and V309I) had a
higher affinity to p3′SL than to p6SL. One virus carrying HA
with the single mutation S219F bound only to p3′SL (Table
2). The results show that mutations that improve replication in
the allantoic cavity promote increased affinity of the virus to
both α2,3- and α2,6-linked SA. However, because the
viruses' affinity to p3′SL is higher than that to p6SL, we
conclude that improved replication in eggs is associated with
the acquisition of specificity to mainly α2,3-containing
receptors.
Relation between antigenicity and the mutations observed
during adaptation in eggs
Vaccine manufacture requires that the modified virus
preserves the antigenicity of the original. To determine whether
the changes that permit virus replication in the allantoic cavity
affect antigenicity, we performed hemagglutination inhibition
(HI) and NA inhibition (NI) assays on all reverse genetics
viruses that replicated well in the allantoic cavity using antisera
and monoclonal antibodies (mAbs) (Table 3).
We were unable to detect any antigenic variation between
wild-type and adapted viruses. Likewise, the adaptation process
did not result in antigenic variation in NA as measured by NI
assay (Table 3). We therefore conclude that, on a PR8 backbone,
the various amino acid substitutions we observed during
adaptation do not substantially influence virus antigenicity.
We found no correlation between the specific mutation(s) in HA
Table 3
Antigenicity of the modified viruses
Virus a HI titer b NI titer b
Antiserum mAb Antiserum mAb
H3 H1 H3 H1 N1 N2 N1 N2
1a Fujian 13 <3 12 <6 <6 12 <6 12
1b PR8 <3 13 <6 12 12 <6 12 <6
2a PR8* <3 12 <6 12 12 <6 11 <6
2b NA wt <3 12 <6 12 <6 12 <6 12
2c NA E119Q, Q136K <3 12 <6 11 <6 12 <6 11
2d HA G186V, V226I; NA wt 12 <3 11 <6 <6 12 <6 12
2e HA G186V, V226I; NA Q136K 12 <3 12 <6 <6 11 <6 12
2f HA G186V, S219F, V226I; NA wt 12 <3 12 <6 <6 12 <6 12
2g HA G186V, S219F, V226I; NA Q136K 12 <3 11 <6 <6 12 <6 12
2h HA G186V, S219F, V226I, V309I; NA wt 12 <3 11 <6 <6 11 <6 11
2i HA G186V, S219F, V226I, V309I; NA Q136K 11 <3 11 <6 <6 12 <6 12
a Group 1, original viruses; group 2, reverse genetics viruses. Wild-type A/PR/8/34 generated by reverse genetics is designated PR8*. A/Fujian/411/2002 (H3N2)
(Fujian) was grown in MDCK cells, and A/PR/8/34 (H1N1) (PR8) was propagated in eggs. The other viruses were generated on a PR8 background with HA and/or NA
or A/Fujian/411/2002 with the indicated substitution(s) and propagated in eggs.
b log2 HI or NI titer.
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and HI or NI titers.
Discussion
We have studied the molecular basis of the adaptation of
viruses in eggs by analyzing the adaptation of A/Fujian/411/
2002 (H3N2) (Fujian), a variant that grows poorly in the egg's
allantoic cavity. We observed 6 amino acid changes (4 in HA
and 2 in NA) during the adaptation of Fujian in eggs. To
establish replication in the allantoic cavity, at least 3 passages in
the amniotic cavity and 1 substitution in NA (E119Q) were
needed. However, to establish full adaptation in the allantoic
cavity, subsequent passages in the allantoic cavity and
additional changes around the globular head region of HA
were necessary. Our data show that 2 substitutions (G186V and
V226I) in the Fujian HA on a PR8 backbone are sufficient to
improve the growth of the virus in eggs. Those substitutions
affect the virus's ability to bind to both α2,3- and α2,6 linkage
receptors and are responsible for the acquisition of specificity to
SAα2,3Gal receptors, but do not affect viral antigenicity.
A report on a similar theme was recently published by Lu et
al. (2005). Briefly, they found that the growth of Fujian on an A/
Ann Arbor/6/66 (H2N2) backbone in eggs is improved if HA
and NA activities are balanced by alteration of at least 2 HA
residues (G186Vand V226I or H183L and V226A) or at least 2
NA residues (E119Q and Q136K). We also found that the
replication of Fujian is improved by introducing 2 substitutions
into HA, G186V and V226I, which were selected during
adaptation. However, our findings are different in that changing
at least 2 NA residues (E119Q and Q136K) did not improve
virus replication in the allantoic cavity, and we did not observe
the HA substitutions H183L and V226A in our adaptation
experiment. Interestingly, Nicolson et al. (2005) found that egg
adaptation of 6+2 PR8/Fujian reassortant virus rescued in Vero
cells was associated with 2 substitutions in HA (H183L andD188Y) and no sequence differences in NA. These different
adaptive mutations demonstrate that there are multiple ways to
improve the replication of Fujian in the allantoic cavity of
embryonated chicken eggs. Selection of the adaptive mutations
may vary depending on the backbone used (Lu et al., 2005 used
A/Ann Arbor/6/66 (H2N2); we used PR8) or on the adaptive
process used (Nicolson et al., 2005 took virus from Vero cells to
the allantoic cavity; ours went from the amniotic cavity to the
allantoic cavity).
In addition, by performing serial passages in the amniotic
and allantoic cavities, we were able to study the time course of
the adaptation of wild-type Fujian in eggs and to pinpoint the
amino acids that contribute to the adaptation process. Our
results suggest that the progression of adaptation in eggs can be
described in 3 steps, and we propose the following hypotheses
for each step. First, MDCK-grown Fujian (and presumably
clinical isolates) can replicate in the amniotic cavity because the
cells of the amniotic cavity in embryonated chicken eggs
possess receptors with α2,6 linkages, which are preferred by
human influenza A virus. Second, variants that can grow in the
amniotic cavity have balanced HA and NA activities; some of
these variants might successfully establish replication in the
allantoic cavity, where only SA(α2,3)Gal-containing receptors
exist. Finally, the virus achieves high growth in the allantoic
cavity as a result of additional changes in HA that compensate
for the low NA activity and restore the balance between the HA
and NA activities. The changes in NA appear to be necessary
for amniotic growth but not for allantoic growth. These
observations emphasize the significance of a balance between
HA and NA activities in virus replication (Wagner et al., 2002):
gain of function in 1 protein may compensate for the loss of
function in the other. Data such as this allow for 2 possible
strategies to make a potential vaccine reference strain from
Fujian: i) passage of clinical material in amniotic cavities until
allanotic adapted or ii) use of reverse genetics to clone HA and
NA (this can be done from MDCK isolated virus), the
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and V226I), then rescue of a 6+2 PR8 reassortant in validated
cells such as Vero cells.
To determine the effect of the adaptation on receptor
specificity, we used a rigorous chemical assay. According to
our chemical assay, viruses bearing HA with either G186V or
V226I bound to both SAα2,3Gal- and SAα2,6Gal-containing
receptors but with higher affinity to the former. Interestingly,
double substitution (G186V and V226I) in HA resulted in an
increase in virus affinity that was similar to that resulting from
single substitution, yet such double substitution virus had clear
greater advantage in the allantoic cavity. This observation
suggests that Fujian gained its efficient replication in eggs by
some mechanism other than improved affinity alone, perhaps by
binding to additional residues in an oligosaccharide receptor. In
addition, viruses with the HA mutation G186V or V226I
replicated better than did virus with the single HA mutation
S219F. Consistently, virus with the substitution G186Vor V226I
bound to both types of receptors, whereas virus with the HA
substitution S219F bound only to SAα2,3Gal-containing
receptor. Positions 186, 219, and 226 are all located within the
receptor-binding pocket of H3 HA. Positions 186 and 226 are
located in areas that have potential interactions with both
SAα2,3Gal- and SAα2,6Gal-containing receptors, although
they are closer to the binding site of SAα2,3Gal-containing
receptors (Eisen et al., 1997). As such, changes in these positions
affect binding to both substrates, although they have more
impact on binding to SAα2,3Gal-containing receptors. Position
219, in contrast, is located in a position that interact with
SAα2,3Gal-containing receptors but is hindered for interaction
with SAα2,6Gal-containing receptor by other amino acid
residues at positions 165, 189, 218, 221, and 246. Until now,
description of influenza virus receptor specificity has primarily
been limited to the differential recognition of Neu5Acα2,3Gal
and Neu5Acα2,6Gal moieties. Moreover, adaptation of human
influenza virus in eggs has been associated with increased
affinity for SAα2,3Gal-containing receptors and decreased
affinity for SAα2,6Gal-containing receptors (Gambaryan et
al., 1999). We have demonstrated that adaptation of Fujian in
eggs is associated with binding to both types of receptors and
that the affinity of binding to SAα2,3Gal-containing receptor is
stronger than that to SAα2,6Gal-containing receptor. The
change in virus receptor specificity associated with adaptation
in eggs correlates with mutations at positions 186 and 226 in HA
(Gambaryan et al., 1999; Matrosovich et al., 1993; Vines et al.,
1998). Our data have demonstrated that substitutions around the
HA receptor-binding site can modulate the receptor specificity
of influenza viruses in subtle but biologically important ways.
In addition to substitutions around the receptor-binding site of
HA (Robertson et al., 1987; Rocha et al., 1993; Williams and
Robertson, 1993), an alteration in the stalk region of HA (V309I)
was also found. Despite its early appearance during adaptation
and its presence in viruses isolated in subsequent passages, this
mutation did not play a role in the replication of virus generated
by reverse genetics on a PR8 backbone. Viruses with at least 1
mutation in the ectodomain of HA, in or near the fusion peptide,
have been shown to have an elevated pH for membrane fusionduring adaptation toMDCK cells (Lin et al., 1997). In addition, a
recent study by Giannecchini et al. showed that there was a
change in the pH of fusion accompanying the adaptation of a
duck virus to turkey (Giannecchini et al., 2006). Our finding of
a similar change near the fusion region suggests that the passage
of virus in eggs also results in the selection of mutants with an
altered fusion pH. Although it is also possible that the V309I
substitution is spurious, it is tempting to speculate that such
changes in or around the fusion peptide are important steps in
the adaptation process to different hosts or substrates.
Overall, this study has shown that more than 1 approach can
be taken to reveal new ways to improve human influenza A
virus replication in the allantoic cavity of eggs. An understand-
ing of adaptation at the molecular level will benefit attempts to
enhance human influenza A virus replication in the substrates
used for vaccine manufacture and, consequently, will help
public health authorities to achieve the important goal of
increasing the availability of influenza vaccine.
Materials and methods
Virus strain, cells, and medium
The influenza A virus used in this study, A/Fujian/411/2002
(H3N2), was obtained from the Centers for Disease Control and
Prevention (CDC), Atlanta, GA and propagated in MDCK cells
(from the American Type Culture Collection [ATCC], Mana-
ssas, VA). MDCK cells were cultured in minimal essential
medium (MEM) supplemented with 5% fetal bovine serum
(FBS) and antibiotics. 293T human embryonic kidney cells
(ATCC) were cultured in OptiMEM I (Gibco, Grand Island,
NY) supplemented with 5% FBS and antibiotics.
Cloning of viral segments, construction of plasmids, and
mutagenesis
Reverse transcription polymerase chain reaction (RT-PCR)
was performed with segment-specific primers as described
elsewhere (Hoffmann et al., 2002). Briefly, RNAwas isolated by
using the RNeasy kit (Qiagen). RNAwas transcribed to cDNA
by using Universal 12 primer (AGC AAA AGC AGG), and the
cDNA was amplified by using segment-specific primers.
Sequencing was performed by the Hartwell Center for
Biotechnology at St. Jude Children's Research Hospital, using
the rhodamine dye-terminator cycle sequencing Ready Reaction
kit with AmpliTaq DNA polymerase FS (Perkin-Elmer Applied
Biosystems). Plasmids with different single or combined
mutations were created by using the Quick-Change site-directed
mutagenesis kit (Stratagene). The amino acid sequences of the
HA proteins of each virus were aligned with that of A/Aichi/2/68
(H3N2) and numbered (H3 numbering) on the basis of the X-ray
crystallographic structure (Sauter et al., 1992).
Generation of reassortant viruses by reverse genetics
Recombinant viruses were generated by using the reverse
genetics techniques described by Hoffmann et al. (2002).
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trypsinized and 0.2 × 106 to 1 × 106 cells of each cell line
cocultured. The cocultured cells were transfected with 1 μg of
each of 8 cDNA plasmids encoding each gene segment and
18 μl of TransIT-LT1 Transfection Reagent (Mirus Bio
Corporation, Madison, WI) made up to a total volume of 1 ml
with OptiMEM I and antibiotics. The DNA–lipid complexes
were removed after 6 h, and fresh medium was added to the cell
cultures. The cells were incubated for an additional 24 h, then
0.5 μg/ml of L-1-(tosylamido-2-phenyl) ethyl chloromethyl
ketone (TPCK)-treated trypsin (Worthington Diagnostics,
Freehold, NJ) was added. After a total of 72 h of incubation,
300 μl of supernatant was injected into the allantoic cavity of
three 10-day-old embryonated chicken eggs, 100 μl per egg,
and 1 ml of supernatant was used to infect MDCK cells in
monolayer. After 48 h, the allantoic fluid was harvested, RNA
was extracted and analyzed by RT-PCR, and each viral segment
was partially sequenced to confirm the identity of the
reassortant virus.
Virus characterization and serologic assays
Hemagglutination assay
Fifty microliters of 0.5% CRBC or TRBC in suspension in
phosphate-buffered saline (PBS) were added to 50 μl of 2-
fold dilutions of virus in PBS, and the mixture was incubated
at room temperature for 45 min. The hemagglutination titer
was calculated as the reciprocal value of the highest virus
dilution that caused complete hemagglutination.
Measurement of NA activity
The activity of NA was determined by using a modified
fluorometric assay with the fluorogenic substrate 2′-(4-
methylumbelliferyl)-D-N-acetylneuraminic acid (MUNANA;
Sigma) (Gubareva et al., 2002; Potier et al., 1979). The
fluorescence of the released 4-methylumbelliferone was
measured in a Fluoroskan II (Labsystems, Helsinki, Finland)
spectrophotometer using excitation and emission wavelengths
of 355 and 460 nm, respectively. Enzyme activity was
expressed as the quantity of fluorogenic substrates being
released (relative emission units at 460 nm). All reactions
were performed twice.
HI and NI assays
The antigenicity of the virus isolates was characterized by
using the HI test (Aymard-Henry et al., 1973) with antisera and
monoclonal antibodies (mAbs) against H3, H1, N1, and N2
subtypes. For the HI assay, we used sheep antiserum to A/
Wyoming/03/2003-like virus (H3 antiserum), goat anti-PR8
serum (H1 antiserum), murine monoclonal anti-A/Memphis/1/
94 (H3 mAbs), and pooled murine mAbs to A/WSN/33 (H1
mAbs). For the NI assay, we used goat antiserum to A/New
Jersey/8/76 (N1 antiserum) and A/Singapore/1/57 (N2 antise-
rum), murine mAb to A/WSN/33 (N1 mAb), and pooled murine
mAbs to A/Memphis/2/85 and A/Memphis/12/85 (N2 mAbs).
H3 antiserum was obtained from the Centers for Disease
Control and Prevention (CDC), Atlanta, GA, and all otherantisera and mAbs were obtained from the St. Jude Children's
Research Hospital repository.
Plaque assay
Plaque assay (Hayden et al., 1980) was performed to
determine virus titer and plaque phenotype. Briefly, confluent
monolayers of MDCK cells were inoculated with 10-fold
dilutions of influenza virus. After 1 h at 37 °C, the inoculum
was removed and the cells were washed and overlaid with
maintenance medium containing 1% agarose, 0.2% serum
albumin, and 2.5 μg/ml of TPCK-treated trypsin (Worthington).
After 3 days of incubation at 37 °C in a humidified atmosphere
of 5% CO2, the cells were stained with 0.1% crystal violet in
37% formaldehyde.
Assay of virus binding to substrates containing SA
The binding of human influenza viruses to fetuin was
performed in a direct solid-phase assay using the immobilized
virus and horseradish-peroxidase (HRP)-conjugated fetuin, as
described previously (Gambaryan and Matrosovich, 1992). The
affinity of viruses to p3′SL and p6SL (Bovin et al., 1993) was
measured in a competitive assay based on the inhibition of
binding of the HRP-labeled fetuin (Matrosovich et al., 1993).
The polyvalent synthetic sialoglycoconjugates p3′SL and p6SL
were synthesized as described earlier (Bovin et al., 1993) and
provided by Dr. N.V. Bovin.
Briefly, 96-well microtiter plates (Costar, Cambridge, MA)
were coated with viruses at a titer of 4−8 hemagglutination units
at 4 °C for 16 h followed by washing with 0.05% Tween 20 in
PBS (PBS-T). After the addition of peroxidase-conjugated
fetuin or synthetic substrate in PBS supplemented with 0.02%
Tween 20, 0.02% BSA, 3 μM of the NA inhibitor 2,3-
didehydro-2,4-dideoxy-4-amino-N-acetyl-D-neuraminic acid,
and, in the case of competitive assay, fetuin, plates were
incubated at 4 °C for 1 h. The initial concentration of p3′SL or
p6SL was 20 μM in SA; 2-fold serial dilutions were used. After
washing with cold PBS-T, substrate solution (0.1 M sodium
acetate [pH 5.0] containing 4 mM o-phenylendiamine [Boeh-
ringer Mannheim, Germany] and 0.004% H2O2) was added for
30 min. The reaction was stopped with 2 M H2SO4. Optical
density was determined at 492 nm with a Multiscan plate reader
(Labsystems, Finland). The dissociation constants (Kdiss) were
determined as the SA (Neu5Ac) concentration at the point
Amax/2 on Scatchard plots. The reported data represent the mean
of at least 4 individual experiments for each virus.
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